99 related articles for article (PubMed ID: 24518673)
1. SVα-MSH, a novel α-melanocyte stimulating hormone analog, ameliorates autoimmune encephalomyelitis through inhibiting autoreactive CD4(+) T cells activation.
Fang J; Han D; Hong J; Zhang H; Ying Y; Tian Y; Zhang L; Lin J
J Neuroimmunol; 2014 Apr; 269(1-2):9-19. PubMed ID: 24518673
[TBL] [Abstract][Full Text] [Related]
2. The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.
Taylor AW; Kitaichi N
Brain Behav Immun; 2008 Jul; 22(5):639-46. PubMed ID: 18171609
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells.
Han D; Tian Y; Zhang M; Zhou Z; Lu J
Gene Ther; 2007 Mar; 14(5):383-95. PubMed ID: 17066098
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive activity of a novel peptide analog of α-melanocyte stimulating hormone (α-MSH) in experimental autoimmune uveitis.
Edling AE; Gomes D; Weeden T; Dzuris J; Stefano J; Pan C; Williams J; Kaplan J; Perricone MA
J Neuroimmunol; 2011 Jul; 236(1-2):1-9. PubMed ID: 21640392
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory action of alpha-melanocyte stimulating hormone (alpha-MSH) in anti-CD3/CD28-mediated spleen and CD4(+)CD25(-) T cells and a partial participation of IL-10.
Chang SH; Jung EJ; Lim DG; Park YH; Wee YM; Kim JH; Kim YH; Choi MY; Koo SK; Choi KD; Han DJ; Kim SC
Immunol Lett; 2008 Jun; 118(1):44-8. PubMed ID: 18395269
[TBL] [Abstract][Full Text] [Related]
6. Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease.
Mykicki N; Herrmann AM; Schwab N; Deenen R; Sparwasser T; Limmer A; Wachsmuth L; Klotz L; Köhrer K; Faber C; Wiendl H; Luger TA; Meuth SG; Loser K
Sci Transl Med; 2016 Oct; 8(362):362ra146. PubMed ID: 27797962
[TBL] [Abstract][Full Text] [Related]
7. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2.
Namba K; Kitaichi N; Nishida T; Taylor AW
J Leukoc Biol; 2002 Nov; 72(5):946-52. PubMed ID: 12429716
[TBL] [Abstract][Full Text] [Related]
8. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
9. Modulation of regulatory T cell immunity by the neuropeptide alpha-melanocyte stimulating hormone.
Taylor AW
Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):143-9. PubMed ID: 12887097
[TBL] [Abstract][Full Text] [Related]
10. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D
J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788
[TBL] [Abstract][Full Text] [Related]
11. A CD4-CDR3 peptide analog inhibits both primary and secondary autoreactive CD4+ T cell responses in experimental allergic encephalomyelitis.
Marini JC; Jameson BA; Lublin FD; Korngold R
J Immunol; 1996 Oct; 157(8):3706-15. PubMed ID: 8871674
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.
Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP
Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971
[TBL] [Abstract][Full Text] [Related]
13. Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis.
Wang J; Lu ZH; Gabius HJ; Rohowsky-Kochan C; Ledeen RW; Wu G
J Immunol; 2009 Apr; 182(7):4036-45. PubMed ID: 19299701
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: reduced priming of proinflammatory effector CD4(+) T cells.
Helmersson S; Sundstedt A; Deronic A; Leanderson T; Ivars F
Am J Pathol; 2013 May; 182(5):1671-80. PubMed ID: 23506849
[TBL] [Abstract][Full Text] [Related]
15. Alpha-melanocyte-stimulating hormone structure-activity studies: comparative analysis of melanotropic and CNS bioactivities.
Sawyer TK; Hadley ME; Hruby VJ; Castrucci AM; Staples DJ; Farah J; O'Donohue TL
Synapse; 1988; 2(3):289-92. PubMed ID: 2850630
[TBL] [Abstract][Full Text] [Related]
16. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.
Zhang X; Reddy J; Ochi H; Frenkel D; Kuchroo VK; Weiner HL
Int Immunol; 2006 Apr; 18(4):495-503. PubMed ID: 16540527
[TBL] [Abstract][Full Text] [Related]
17. Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis.
Othy S; Hegde P; Topçu S; Sharma M; Maddur MS; Lacroix-Desmazes S; Bayry J; Kaveri SV
J Immunol; 2013 May; 190(9):4535-41. PubMed ID: 23526819
[TBL] [Abstract][Full Text] [Related]
18. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.
Karpus WJ; Lukacs NW; McRae BL; Strieter RM; Kunkel SL; Miller SD
J Immunol; 1995 Nov; 155(10):5003-10. PubMed ID: 7594507
[TBL] [Abstract][Full Text] [Related]
19. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
[TBL] [Abstract][Full Text] [Related]
20. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
